Letter to the editor: Exacerbation of autoimmune hepatitis after COVID‐19 vaccination
Zhujun Cao, Honglian Gui, Zike Sheng, Haiguang Xin, Qing Xie – 3 December 2021
Big Data for Small People: How Novel Data Collection Can Improve Pediatric Transplantation Outcomes
M. Andrew Millis, Shannon L. Cramm, Michael Englesbe – 2 December 2021
Reply
Andrew I. Aronsohn, Debika Bhattacharya, Timothy R. Morgan, David L. Wyles, Raymond T. Chung, Daniel P. McQuillen, AASLD‐IDSA HCV Guidance – 2 December 2021
Practices and Perceptions of Living Donor Liver Transplantation, Nondirected Donation, and Liver Paired Exchange: A National Survey
Alyson Kaplan, Russell Rosenblatt, Whitney Jackson, Benjamin Samstein, Robert S. Brown – 2 December 2021 – Living donor liver transplantation (LDLT) remains underutilized in the United States. Barriers to LDLT and acceptance of nondirected living liver donation (ND‐LLD) and liver paired exchange (LPE) are unclear. The medical and surgical directors of 99 unique transplantation programs (56 LDLT programs and 43 non‐LDLT programs) were surveyed to gain insight into perceptions and practices of LDLT and types of donors utilized. The response rate was 84%.
Secondary Prophylaxis of Gastric Variceal Bleeding: A Systematic Review and Network Meta‐Analysis
Karim T. Osman, Tarek Nayfeh, Ahmed M. Abdelfattah, Khaled Alabdallah, Bashar Hasan, Mohammed Firwana, Homam Alabaji, Lina Elkhabiry, Jehan Mousa, Larry J. Prokop, M. Hassan Murad, Fredric Gordon – 2 December 2021 – There is no clear consensus regarding the optimal approach for secondary prophylaxis of gastric variceal bleeding (GVB) in patients with cirrhosis. We conducted a systematic review and network meta‐analysis (NMA) to compare the efficacy of available treatments.
The liver emoji
Adi Balk, Jarone Lee, Christian Renne, Shuhan He – 2 December 2021
The use of nondirected donor organs in living donor liver transplantation: Perspectives and guidance
Alyson N. Fox, AnnMarie Liapakis, Ramesh Batra, Therese Bittermann, Juliet Emamaullee, Sukru Emre, Yuri Genyk, Hyosun Han, Whitney Jackson, Elizabeth Pomfret, Muhammad Raza, Manuel Rodriguez‐Davalos, Susan Rubman Gold, Benjamin Samstein, Akhil Shenoy, Timucin Taner, John P.
A phase 2 dose‐finding study of lonafarnib and ritonavir with or without interferon alpha for chronic delta hepatitis
Cihan Yurdaydin, Onur Keskin, Esra Yurdcu, Aysun Çalişkan, Soner Önem, Fatih Karakaya, Çağdaş Kalkan, Ersin Karatayli, Senem Karatayli, Ingrid Choong, David Apelian, Christopher Koh, Theo Heller, Ramazan Idilman, A. Mithat Bozdayi, Jeffrey S. Glenn – 2 December 2021
Liver Transplantation for Intrahepatic Cholangiocarcinoma: Ready for Prime Time?
Gonzalo Sapisochin, Tommy Ivanics, Julie Heimbach – 2 December 2021 – Cholangiocarcinoma (CCA) represents the second‐most common primary liver malignancy after HCC and has risen in incidence globally in the past decades. Intrahepatic cholangiocarcinoma (iCCA) comprises 20% of all CCAs, with the rest being extrahepatic (including perihilar [pCCA] and distal CCA). Though long representing an absolute contraindication for liver transplantation (LT), recent analyses of outcomes of LT for iCCA have suggested that iCCA may be a potentially feasible option for highly selected patients.
Severe Alcohol‐Associated Hepatitis Is Associated With Worse Survival in Critically Ill Patients With Acute on Chronic Liver Failure
Kavish R. Patidar, Jennifer L. Peng, Harleen Kaur, Astin Worden, Carla D. Kettler, Francis Pike, Caitriona A. Buckley, Eric S. Orman, Archita P Desai, Lauren D. Nephew, Chandrashekhar A. Kubal, Samer Gawrieh, Naga Chalasani, Marwan S. Ghabril – 2 December 2021 – Differences in mortality between critically ill patients with severe alcohol‐associated hepatitis (sAH) and acute‐on‐chronic liver failure (ACLF) and non‐sAH ACLF (i.e., ACLF not precipitated by sAH) are unknown. Such differences are important, as they may inform on prognosis and optimal timing of liver transplantation (LT).